Sameer Parekh

592 total citations
27 papers, 372 citations indexed

About

Sameer Parekh is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Sameer Parekh has authored 27 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Microbiology and 11 papers in Infectious Diseases. Recurrent topics in Sameer Parekh's work include Bacterial Infections and Vaccines (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Pneumonia and Respiratory Infections (6 papers). Sameer Parekh is often cited by papers focused on Bacterial Infections and Vaccines (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Pneumonia and Respiratory Infections (6 papers). Sameer Parekh collaborates with scholars based in India, Czechia and United Kingdom. Sameer Parekh's co-authors include Shuping Tong, Christian Trépo, Jack R. Wands, Jisu Li, S Kawai, Fabien Zoulim, Sang Hoon Ahn, Hitt Sharma, Suresh Jadhav and Subhash V. Kapre and has published in prestigious journals such as Journal of Virology, Frontiers in Immunology and Vaccine.

In The Last Decade

Sameer Parekh

22 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sameer Parekh India	10	302	193	58	52	33	27	372
Nina G. Barzaga Philippines	10	191 0.6×	198 1.0×	109 1.9×	4 0.1×	9 0.3×	14	373
Maja M. Lunar Slovenia	11	173 0.6×	72 0.4×	112 1.9×	12 0.2×	3 0.1×	35	271
Emanoil Ceaușu Romania	10	123 0.4×	79 0.4×	109 1.9×	10 0.2×	5 0.2×	45	243
Helena Medina Cruz Brazil	12	303 1.0×	281 1.5×	86 1.5×	6 0.1×	4 0.1×	28	396
Jeff Furlong United States	6	156 0.5×	14 0.1×	57 1.0×	13 0.3×	13 0.4×	13	507
E. Pornaro Italy	9	341 1.1×	298 1.5×	28 0.5×	12 0.2×	2 0.1×	16	380
R. Monica Lascar United Kingdom	7	326 1.1×	253 1.3×	91 1.6×	14 0.3×	2 0.1×	8	410
István Jankovics Hungary	10	299 1.0×	13 0.1×	112 1.9×	10 0.2×	28 0.8×	22	362
John Law Canada	11	148 0.5×	169 0.9×	45 0.8×	13 0.3×		16	325
Han-hua Fang China	7	403 1.3×	32 0.2×	148 2.6×	6 0.1×	40 1.2×	18	448

Countries citing papers authored by Sameer Parekh

Since Specialization

Citations

This map shows the geographic impact of Sameer Parekh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Parekh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Parekh more than expected).

Fields of papers citing papers by Sameer Parekh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer Parekh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Parekh. The network helps show where Sameer Parekh may publish in the future.

Co-authorship network of co-authors of Sameer Parekh

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer Parekh. A scholar is included among the top collaborators of Sameer Parekh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer Parekh. Sameer Parekh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gautam, Manish, Kevin Markey, Sumit Gupta, et al.. (2025). Quantitative bead–based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples. Frontiers in Immunology. 16. 1587567–1587567.

May, Marcus, Fabio Pisano, Leander Grode, et al.. (2023). Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany. Vaccine. 41(46). 6810–6819. 1 indexed citations

Addepalli, Veeranjaneyulu, et al.. (2023). Sub-Acute Toxicity Study of Hydro-Alcoholic Extracts of <i>Sansevieria cylindrica</i> and <i>Plumeria obtusa</i> in Wistar Albino Rats. Toxicology International. 537–558.

Sharma, Hitt, Sameer Parekh, Akash J. Patel, et al.. (2023). A Phase I study to evaluate safety and tolerability of DTaP-IPV + Hib vaccine in healthy adult volunteers in India. Vaccine X. 14. 100300–100300. 1 indexed citations

Sharma, Hitt, et al.. (2023). A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults. Vaccine X. 14. 100313–100313. 2 indexed citations

Sharma, Hitt, Sanjay Lalwani, Sameer Parekh, et al.. (2022). A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months. Human Vaccines & Immunotherapeutics. 18(6). 2146435–2146435. 4 indexed citations

Sharma, Hitt, et al.. (2021). A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults. Vaccine. 39(6). 882–885. 1 indexed citations

Sood, Rajeev, et al.. (2020). A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 38(5). 433–439. 9 indexed citations

Sharma, Hitt, Sangeeta Yadav, Sanjay Lalwani, et al.. (2012). Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine. Vaccine. 31(3). 444–447. 11 indexed citations

10.

Sharma, Hitt, Subhash V. Kapre, Suresh Jadhav, et al.. (2012). A phase III, randomized controlled study to assess the safety and immunogenicity of a semi-synthetic diphtheria, tetanus and whole-cell pertussis vaccine in Indian infants. Vaccine. 30(43). 6157–6162.

11.

Sharma, Hitt, Sanjay Lalwani, Vijay Gupta, et al.. (2011). A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants. Vaccine. 29(13). 2359–2364. 15 indexed citations

12.

Sharma, Hitt, et al.. (2011). A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6–14 weeks. Vaccine. 29(48). 8773–8779. 2 indexed citations

13.

Sharma, Hitt, V S Padbidri, Subhash V. Kapre, et al.. (2011). Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. The Journal of Infection in Developing Countries. 5(12). 874–881. 26 indexed citations

14.

Sharma, Hitt, Sanjay Lalwani, Subhash V. Kapre, et al.. (2011). Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children. Human Vaccines. 7(4). 451–457. 20 indexed citations

15.

Sharma, Hitt, Sanjay Lalwani, Mamta Manglani, et al.. (2011). Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process. Vaccine. 30(3). 510–516. 10 indexed citations

16.

Bitragunta, Sailaja, Manoj Murhekar, Anita Chakravarti, et al.. (2010). Safety and immunogenicity of single dose of tetanus–diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007. Vaccine. 28(37). 5934–5938. 3 indexed citations

17.

Sharma, Hitt, et al.. (2010). Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls. Indian Journal of Community Medicine. 35(1). 134–134. 16 indexed citations

18.

Sharma, Hitt, et al.. (2009). Safety and immunogenicity of an indigenously developedHaemophilus influenzaetype b conjugate vaccine through various phases of clinical trials. Human Vaccines. 5(7). 483–487. 4 indexed citations

19.

Sharma, Hitt, et al.. (2009). Safety and immunogenicity of diphtheria-tetanus-pertussis vaccine and hepatitis B vaccine as a new tetravalent combination (DTwP/HB) administered alone and at separate sites (DTwP & HB) including comparison with standard commercially available combination vaccine in Indian infants 6-14 weeks of age. Human Vaccines. 5(5). 310–314. 1 indexed citations

20.

Parekh, Sameer. (1996). Prospects for remailers. First Monday. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact